Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 and Salvatore Scaffidi, who joined the Ysios Fellowship program in 2020, has been promoted to Associate.
Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.
